Lisata Therapeutics, Inc. (FRA:8NE)

Germany flag Germany · Delayed Price · Currency is EUR
1.660
+0.090 (5.73%)
At close: Dec 5, 2025
-34.13%
Market Cap 14.94M
Revenue (ttm) 911.96K
Net Income (ttm) -15.55M
Shares Out n/a
EPS (ttm) -1.81
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 1.660
Previous Close 1.570
Day's Range 1.660 - 1.660
52-Week Range 1.550 - 3.660
Beta n/a
RSI 43.14
Earnings Date Feb 27, 2026

About Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with a range of anti-cancer regimens. The company was incorporated in 1980 and is hea... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1980
Employees 26
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 8NE
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.